Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-15, with 59 holding rows worth $561,747,000.

Accession
0001493152-18-011949
Filed
2018-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 59 entries on the cover page, a total value of $561,747,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $561,747,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNOMEDICS INC452907108COM4,750,000$112,433,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM4,025,000$51,520,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM1,162,000$45,562,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR453,233$37,555,000thousands by filing date
KADMON HLDGS INC48283N106COM9,060,014$36,149,000thousands by filing date
VERACYTE INC COM92337F107Stock2,660,210$24,846,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM2,030,533$22,539,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR311,111$20,695,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM1,030,330$14,012,000thousands by filing date
IRIDEX CORP462684101COM2,000,000$13,920,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS2,962,568$13,035,000thousands by filing date
Viewra, Inc92672L107COM1,495,000$10,345,000thousands by filing date
CAS MED SYS INC124769209COM5,263,508$10,264,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock34,803$9,734,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM830,000$9,686,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH100,000$9,519,000thousands by filing dateput
SAREPTA THERAPEUTICS INC803607100COM60,000$7,931,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM750,000$7,118,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock20,000$6,900,000thousands by filing dateput
ISHARES TR464287234MSCI EMG MKT ETF150,000$6,500,000thousands by filing dateput
ObsEva SAH5861P103COM424,300$6,424,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM160,000$6,323,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM147,500$5,783,000thousands by filing datecall
ZOGENIX INC.98978L204Common Stock110,500$4,884,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM345,000$4,830,000thousands by filing date
CUTERA INC232109108COM105,000$4,232,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock450,000$4,140,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM61,000$4,122,000thousands by filing dateput
APELLIS PHARMACEUTICALS INC03753U106COM168,000$3,696,000thousands by filing date
ZOGENIX INC.98978L204Common Stock82,500$3,647,000thousands by filing datecall
MEI PHARMA INC55279B202COM NEW880,087$3,468,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/03,000,000$3,022,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM200,000$2,720,000thousands by filing datecall
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK250,000$2,610,000thousands by filing date
ZAFGEN INC98885E103COM250,000$2,558,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM190,000$2,432,000thousands by filing datecall
ACER THERAPEUTICS INC00444P108CMN109,270$2,360,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock170,000$2,295,000thousands by filing date
TESARO INC881569107COM50,000$2,224,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM53,800$2,126,000thousands by filing datecall
ZOGENIX INC.98978L204Common Stock45,000$1,989,000thousands by filing dateput
VERICEL CORP92346J108COM190,055$1,844,000thousands by filing date
EDITAS MEDICINE INC28106W103COM50,000$1,792,000thousands by filing datecall
KEZAR LIFE SCIENCES INC49372L100COM100,000$1,730,000thousands by filing date
DEUTSCHE BK AG NAMEN AKTD18190898Stock150,000$1,593,000thousands by filing dateput
FORTY SEVEN INC34983P104COM73,000$1,168,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock25,000$980,000thousands by filing dateput
AMAG PHARMACEUTICALS INC00163U106COM50,000$975,000thousands by filing dateput
ALIMERA SCIENCES INC016259103COM974,318$953,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM50,000$824,000thousands by filing dateput
STAAR SURGICAL CO COM PAR $0.01852312305Stock25,000$775,000thousands by filing dateput
VIVEVE MED INC92852W204COM NEW267,500$728,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM50,000$700,000thousands by filing datecall
POLARITYTE INC731094108COM25,000$589,000thousands by filing dateput
ZYNERBA PHARMACEUTICALS INC98986X109COM50,000$487,000thousands by filing dateput
MANNKIND CORP COM NEW56400P706Stock107,500$204,000thousands by filing dateput
ROCKWELL MED INC774374102COM25,000$123,000thousands by filing dateput
TRANSENTERIX INC89366M201COM NEW25,000$109,000thousands by filing dateput
ONCOBIOLOGICS INC68235M105COM29,082$25,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-18-011949this filing2018-08-15acceptance time not in the bulk data set